XRAY’s EDS and Wellspect are the keys to stabilizing their results going forward. OIS and CTS continue to decline, but SureSmile grows in Europe. Their new CEO will also prioritize execution rather ...
XRAY remains lacks statistical advantages against industry peers in key metrics. The business benefitted from COVID-19 but now faces lower earnings and compressed margins. Management's 6% return on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results